0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Journal Articles

in Psychopharmacology
Sign in to download this free article PDF

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Psychiatry
Original Investigation  | 
Venlafaxine Extended-Release for Depression Following Spinal Cord Injury:  A Randomized Clinical Trial
Jesse R. Fann, MD, MPH; Charles H. Bombardier, PhD; J. Scott Richards, PhD; et al.
JAMA Psychiatry
Viewpoint  | 
Retaining Part D’s Comprehensive Coverage of Antidepressants:  Not a Silver Bullet
Yuhua Bao, PhD; Yan Tang, MS; Julie Donohue, PhD
JAMA Psychiatry
Research Letter  | 
Emergency Department Visits by Children and Adolescents for Antipsychotic Drug Adverse Events
Lee M. Hampton, MD, MSc; Matthew Daubresse, MHS; Hsien-Yen Chang, PhD; et al.
JAMA Psychiatry
Original Investigation  | 
Changes in Drug Coverage Generosity and Untreated Serious Mental Illness:  Transitioning From Medicaid to Medicare Part D
Jeanne M. Madden, PhD; Alyce S. Adams, PhD; Robert F. LeCates, MA; et al.